INSIGHTS ON DRUG DEVELOPMENT
-
![Tumor-cancer cell-GettyImages-1405940919]( "Analyzing Biological Drug Effects In 3D")
Analyzing Biological Drug Effects In 3DExplore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.
-
![GettyImages-1221368766-lab-PPE-cleanroom]( "Increasing Precision And Cost Efficiency In The Lab With Gas Mixing")
Increasing Precision And Cost Efficiency In The Lab With Gas MixingUnderstanding how cells function drives progress in disease research and drug discovery. Precise control of cellular environments is essential for reliable experiments and therapeutic development.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "3 Key Considerations In Gene Therapy Manufacturing")
3 Key Considerations In Gene Therapy ManufacturingViral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
-
![Innovations in medicine-GettyImages-1193139686]( "Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)")
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
The Rise Of Complex OSD Generics: Understanding Development Challenges12/11/2024
Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.
-
How The Accelerator™ Drug Development Model Enhances eNPV2/25/2026
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform4/22/2025
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
What Will It Take To Make MCED And MRD A Reality?6/30/2026
Cancer mortality is declining, but the need for earlier action remains. Gain insight into how MCED and MRD are advancing cancer detection and surveillance, helping clinicians identify disease sooner.
-
Rheology Is An Accurate Predictor Of Pharmaceutical Lotion Stability5/6/2026
Rheological creep testing provides a rapid way to predict pharmaceutical lotion stability by linking steady-state viscosity to particle settling behavior, enabling reliable shelf-life estimates.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-950086574-microscope-scientist-pill-development]( "Developing Pediatric Formulations")
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.
-
![molecular-devices-clone-select-imager-fl]( "High-Speed Fluorescence And White Light Imaging With The CloneSelect Imager")
Next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types
Demonstrating that cell lines are monoclonal – or that a gene was edited as expected – can be a time-consuming and highly-subjective process when relying on conventional technologies. The CloneSelect® Imager and CloneSelect® Imager FL are a high-throughput automated solutions for imaging and analyzing mammalian cells. Tracking the formation of a colony from a single cell is effortless as barcoded plates are tracked over time. Automated acquisition and analysis provides accurate, objective, and consistent results.
-
![Upperton-Formulation Development]( "Formulation Development")
Upperton offers formulation development services to accelerate First-in-Human studies and advance projects toward clinical trials.
-
![GettyImages-1131583289-scientists-laboratory-monitor-screen-computer]( "Generate IUPAC Names From Chemical Structures")
Get Systematic Chemical Names for Structures, and Produce Structures from Names
ACD/Name generates chemical names according to IUPAC rules, converts chemical names to structures, and easily handles challenging areas of nomenclature.
- Generate names for organic; biochemical; and some inorganic, organometallic, and polymer structures
- Convert systematic or trivial names to structures
-
![Waters]( "LC And LC-MS Chemistry Consumables For Bioseparations")
Waters series of chromatography columns and standards offer scientists the diverse range of chromatographic selectivities needed to help characterize today's biotherapeutics and biosimilars.
